Amalgamated Bank’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $757K | Buy |
|
|||||
|
2025
Q1 | $581K | Buy |
|
|||||
|
2024
Q4 | $75K | Sell |
|
|||||
|
2024
Q3 | $66K | Hold |
|
|||||
|
2024
Q2 | $70K | Buy |
|
|||||
|
2024
Q1 | $76K | Sell |
|
|||||
|
2023
Q4 | $547K | Sell |
|
|||||
|
2023
Q3 | $389K | Buy |
|
|||||
|
2023
Q2 | $441K | Buy |
|
|||||
|
2023
Q1 | $321K | Sell |
|
|||||
|
2022
Q4 | $316K | Buy |
|
|||||
|
2022
Q3 | $315K | Buy |
|
|||||
|
2022
Q2 | $267K | Sell |
|
|||||
|
2022
Q1 | $475K | Sell |
|
|||||
|
2021
Q4 | $492K | Sell |
|
|||||
|
2021
Q3 | $355K | Sell |
|
|||||
|
2021
Q2 | $551K | Buy |
|
|||||
|
2021
Q1 | $531K | Sell |
|
|||||
|
2020
Q4 | $1.2M | Sell |
|
|||||
|
2020
Q3 | $923K | Sell |
|
|||||
|
2020
Q2 | $1.1M | Buy |
|
|||||
|
2020
Q1 | $850K | Sell |
|
|||||
|
2019
Q4 | $889K | Buy |
|
|||||
|
2019
Q3 | $673K | Sell |
|
|||||
|
2019
Q2 | $506K | Buy |
|
|||||
|
2019
Q1 | $463K | Buy |
|
|||||
|
2018
Q4 | $232K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $230K | Sell |
|
|||||
|
2018
Q1 | $472K | Buy |
|
|||||
|
2017
Q4 | $593K | Buy |
|
|||||
|
2017
Q3 | $688K | Buy |
|
|||||
|
2017
Q2 | $499K | Buy |
|
|||||
|
2017
Q1 | $480K | Sell |
|
|||||
|
2016
Q4 | $492K | Buy |
|
|||||
|
2016
Q3 | $474K | Buy |
|
|||||
|
2016
Q2 | $460K | Buy |
|
|||||
|
2016
Q1 | $248K | Buy |
|
|||||
|
2015
Q4 | $273K | Sell |
|
|||||
|
2015
Q3 | $276K | Buy |
|
|||||
|
2015
Q2 | $345K | Buy |
|
|||||
|
2015
Q1 | $244K | Buy |
|
|||||
|
2014
Q4 | $228K | Buy |
|